Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXC8
|
ENSG00000037965.6 | homeobox C8 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXC8 | hg38_v1_chr12_+_54008961_54009005 | 0.08 | 6.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_68815991 | 3.28 |
ENST00000265403.12
ENST00000458688.2 |
UGT2B10
|
UDP glucuronosyltransferase family 2 member B10 |
chr4_+_69096494 | 3.27 |
ENST00000508661.5
ENST00000622664.1 |
UGT2B7
|
UDP glucuronosyltransferase family 2 member B7 |
chr4_+_69096467 | 3.23 |
ENST00000305231.12
|
UGT2B7
|
UDP glucuronosyltransferase family 2 member B7 |
chr16_-_31428325 | 3.19 |
ENST00000287490.5
|
COX6A2
|
cytochrome c oxidase subunit 6A2 |
chr5_+_55102635 | 3.08 |
ENST00000274306.7
|
GZMA
|
granzyme A |
chr1_+_196977550 | 2.94 |
ENST00000256785.5
|
CFHR5
|
complement factor H related 5 |
chr20_-_7940444 | 2.84 |
ENST00000378789.4
|
HAO1
|
hydroxyacid oxidase 1 |
chr6_+_160702238 | 2.82 |
ENST00000366924.6
ENST00000308192.14 ENST00000418964.1 |
PLG
|
plasminogen |
chr9_-_114074969 | 2.77 |
ENST00000466610.6
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr10_+_5196831 | 2.72 |
ENST00000263126.3
|
AKR1C4
|
aldo-keto reductase family 1 member C4 |
chr14_+_21868822 | 2.65 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr5_+_76609091 | 2.65 |
ENST00000514001.5
ENST00000396234.7 ENST00000509074.5 ENST00000502745.5 |
IQGAP2
|
IQ motif containing GTPase activating protein 2 |
chr6_-_81752671 | 2.59 |
ENST00000320172.11
ENST00000369754.7 ENST00000369756.3 |
TENT5A
|
terminal nucleotidyltransferase 5A |
chr2_+_1414382 | 2.56 |
ENST00000423320.5
ENST00000346956.7 ENST00000382198.5 |
TPO
|
thyroid peroxidase |
chr4_+_73404255 | 2.47 |
ENST00000621628.4
ENST00000621085.4 ENST00000415165.6 ENST00000295897.9 ENST00000503124.5 ENST00000509063.5 ENST00000401494.7 |
ALB
|
albumin |
chr12_+_100503352 | 2.43 |
ENST00000551379.5
ENST00000188403.7 |
NR1H4
|
nuclear receptor subfamily 1 group H member 4 |
chr3_-_120682215 | 2.37 |
ENST00000283871.10
|
HGD
|
homogentisate 1,2-dioxygenase |
chr2_+_134838610 | 2.32 |
ENST00000356140.10
ENST00000392928.5 |
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr10_+_113553039 | 2.29 |
ENST00000351270.4
|
HABP2
|
hyaluronan binding protein 2 |
chr8_+_133113483 | 2.25 |
ENST00000521107.1
|
TG
|
thyroglobulin |
chr2_+_79120474 | 2.24 |
ENST00000233735.2
|
REG1A
|
regenerating family member 1 alpha |
chr1_+_196943738 | 2.17 |
ENST00000367415.8
ENST00000367421.5 ENST00000649283.1 ENST00000476712.6 ENST00000496448.6 ENST00000473386.1 ENST00000649960.1 |
CFHR2
|
complement factor H related 2 |
chr1_+_159587817 | 2.14 |
ENST00000255040.3
|
APCS
|
amyloid P component, serum |
chr1_+_196774813 | 2.12 |
ENST00000471440.6
ENST00000391985.7 ENST00000617219.1 ENST00000367425.9 |
CFHR3
|
complement factor H related 3 |
chr4_-_71784046 | 2.09 |
ENST00000513476.5
ENST00000273951.13 |
GC
|
GC vitamin D binding protein |
chr16_+_72056153 | 2.09 |
ENST00000576168.6
ENST00000567185.7 ENST00000567612.2 |
HP
|
haptoglobin |
chr10_-_52772763 | 2.00 |
ENST00000675947.1
ENST00000674931.1 |
MBL2
|
mannose binding lectin 2 |
chr11_+_18266254 | 1.92 |
ENST00000532858.5
ENST00000649195.1 ENST00000356524.9 ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
chr17_-_66220630 | 1.92 |
ENST00000585162.1
|
APOH
|
apolipoprotein H |
chr4_-_70666961 | 1.90 |
ENST00000510437.5
|
JCHAIN
|
joining chain of multimeric IgA and IgM |
chr20_+_57561103 | 1.88 |
ENST00000319441.6
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 |
chr12_+_112906949 | 1.87 |
ENST00000679971.1
ENST00000675868.2 ENST00000550883.2 ENST00000553152.2 ENST00000202917.10 ENST00000679467.1 ENST00000680659.1 ENST00000540589.3 ENST00000552526.2 ENST00000681228.1 ENST00000680934.1 ENST00000681700.1 ENST00000679987.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1 |
chr1_-_151831837 | 1.86 |
ENST00000652040.1
|
RORC
|
RAR related orphan receptor C |
chr6_-_134950081 | 1.85 |
ENST00000367847.2
ENST00000265605.7 ENST00000367845.6 |
ALDH8A1
|
aldehyde dehydrogenase 8 family member A1 |
chr12_-_14843517 | 1.84 |
ENST00000228936.6
|
ART4
|
ADP-ribosyltransferase 4 (inactive) (Dombrock blood group) |
chr4_-_70666492 | 1.81 |
ENST00000254801.9
ENST00000391614.7 |
JCHAIN
|
joining chain of multimeric IgA and IgM |
chr2_-_88947820 | 1.81 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr1_+_196888014 | 1.80 |
ENST00000367416.6
ENST00000608469.6 ENST00000251424.8 ENST00000367418.2 |
CFHR4
|
complement factor H related 4 |
chr17_-_28368012 | 1.79 |
ENST00000555059.2
|
ENSG00000273171.1
|
novel protein, readthrough between VTN and SEBOX |
chr7_+_138076453 | 1.75 |
ENST00000242375.8
ENST00000411726.6 |
AKR1D1
|
aldo-keto reductase family 1 member D1 |
chr6_+_131573219 | 1.71 |
ENST00000356962.2
ENST00000368087.8 ENST00000673427.1 ENST00000640973.1 |
ARG1
|
arginase 1 |
chrY_+_12904102 | 1.70 |
ENST00000360160.8
ENST00000454054.5 |
DDX3Y
|
DEAD-box helicase 3 Y-linked |
chr1_-_46941425 | 1.70 |
ENST00000371904.8
|
CYP4A11
|
cytochrome P450 family 4 subfamily A member 11 |
chr4_+_22692906 | 1.69 |
ENST00000613293.4
ENST00000610628.4 |
GBA3
|
glucosylceramidase beta 3 (gene/pseudogene) |
chr16_-_71577082 | 1.69 |
ENST00000355962.5
|
TAT
|
tyrosine aminotransferase |
chr19_+_7763210 | 1.68 |
ENST00000359059.10
ENST00000596363.5 ENST00000394122.7 ENST00000327325.10 |
CLEC4M
|
C-type lectin domain family 4 member M |
chr3_+_149474688 | 1.68 |
ENST00000305354.5
ENST00000465758.1 |
TM4SF4
|
transmembrane 4 L six family member 4 |
chr15_-_53733103 | 1.67 |
ENST00000559418.5
|
WDR72
|
WD repeat domain 72 |
chr1_-_151831768 | 1.63 |
ENST00000318247.7
|
RORC
|
RAR related orphan receptor C |
chr4_+_186266183 | 1.62 |
ENST00000403665.7
ENST00000492972.6 ENST00000264692.8 |
F11
|
coagulation factor XI |
chr4_-_40515967 | 1.59 |
ENST00000381795.10
|
RBM47
|
RNA binding motif protein 47 |
chr11_+_60455839 | 1.58 |
ENST00000532491.5
ENST00000532073.5 ENST00000345732.9 ENST00000534668.6 ENST00000528313.1 ENST00000533306.6 ENST00000674194.1 |
MS4A1
|
membrane spanning 4-domains A1 |
chr12_+_103587266 | 1.58 |
ENST00000388887.7
|
STAB2
|
stabilin 2 |
chr7_+_138076422 | 1.57 |
ENST00000432161.5
|
AKR1D1
|
aldo-keto reductase family 1 member D1 |
chr9_-_101430861 | 1.57 |
ENST00000649902.1
|
ALDOB
|
aldolase, fructose-bisphosphate B |
chr1_+_196819731 | 1.56 |
ENST00000320493.10
ENST00000367424.4 |
CFHR1
|
complement factor H related 1 |
chr14_-_105856183 | 1.56 |
ENST00000637539.2
ENST00000390559.6 |
IGHM
|
immunoglobulin heavy constant mu |
chr4_-_69495861 | 1.55 |
ENST00000512583.5
|
UGT2B4
|
UDP glucuronosyltransferase family 2 member B4 |
chr4_-_69495897 | 1.54 |
ENST00000305107.7
ENST00000639621.1 |
UGT2B4
|
UDP glucuronosyltransferase family 2 member B4 |
chr19_-_15898057 | 1.53 |
ENST00000011989.11
ENST00000221700.11 |
CYP4F2
|
cytochrome P450 family 4 subfamily F member 2 |
chr5_-_135954962 | 1.51 |
ENST00000522943.5
ENST00000514447.2 ENST00000274507.6 |
LECT2
|
leukocyte cell derived chemotaxin 2 |
chr14_-_106301848 | 1.47 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chrY_+_2841594 | 1.45 |
ENST00000250784.13
|
RPS4Y1
|
ribosomal protein S4 Y-linked 1 |
chr3_+_151814102 | 1.44 |
ENST00000232892.12
|
AADAC
|
arylacetamide deacetylase |
chr12_-_52926459 | 1.42 |
ENST00000552150.5
|
KRT8
|
keratin 8 |
chr11_-_13496018 | 1.42 |
ENST00000529816.1
|
PTH
|
parathyroid hormone |
chr12_-_14951106 | 1.42 |
ENST00000541644.5
ENST00000545895.5 |
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
chr7_+_142529268 | 1.42 |
ENST00000612787.1
|
TRBV7-9
|
T cell receptor beta variable 7-9 |
chr10_-_100065394 | 1.40 |
ENST00000441382.1
|
CPN1
|
carboxypeptidase N subunit 1 |
chr12_+_112906777 | 1.39 |
ENST00000452357.7
ENST00000445409.7 |
OAS1
|
2'-5'-oligoadenylate synthetase 1 |
chr3_+_151814069 | 1.39 |
ENST00000488869.1
|
AADAC
|
arylacetamide deacetylase |
chr10_-_100081854 | 1.39 |
ENST00000370418.8
|
CPN1
|
carboxypeptidase N subunit 1 |
chr2_-_88128049 | 1.37 |
ENST00000393750.3
ENST00000295834.8 |
FABP1
|
fatty acid binding protein 1 |
chr4_-_68951763 | 1.36 |
ENST00000251566.9
|
UGT2A3
|
UDP glucuronosyltransferase family 2 member A3 |
chr2_+_233671879 | 1.35 |
ENST00000354728.5
|
UGT1A9
|
UDP glucuronosyltransferase family 1 member A9 |
chr9_+_134880806 | 1.35 |
ENST00000291744.11
ENST00000350339.3 |
FCN2
|
ficolin 2 |
chr10_+_94938649 | 1.34 |
ENST00000461906.1
ENST00000260682.8 |
CYP2C9
|
cytochrome P450 family 2 subfamily C member 9 |
chr3_-_194351290 | 1.31 |
ENST00000429275.1
ENST00000323830.4 |
CPN2
|
carboxypeptidase N subunit 2 |
chr14_-_94323324 | 1.30 |
ENST00000341584.4
|
SERPINA6
|
serpin family A member 6 |
chr2_-_89213917 | 1.29 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr5_-_151347552 | 1.29 |
ENST00000335244.9
ENST00000521967.1 |
SLC36A2
|
solute carrier family 36 member 2 |
chr2_+_167187283 | 1.29 |
ENST00000409605.1
ENST00000409273.6 |
XIRP2
|
xin actin binding repeat containing 2 |
chr12_+_14803649 | 1.28 |
ENST00000330828.3
|
C12orf60
|
chromosome 12 open reading frame 60 |
chr17_+_4950147 | 1.28 |
ENST00000522301.5
|
ENO3
|
enolase 3 |
chr20_+_44401222 | 1.28 |
ENST00000316099.9
|
HNF4A
|
hepatocyte nuclear factor 4 alpha |
chr14_-_106360320 | 1.28 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
chr1_-_46941464 | 1.28 |
ENST00000462347.5
ENST00000371905.1 ENST00000310638.9 |
CYP4A11
|
cytochrome P450 family 4 subfamily A member 11 |
chr13_-_46105009 | 1.24 |
ENST00000439329.5
ENST00000674625.1 ENST00000181383.10 |
CPB2
|
carboxypeptidase B2 |
chr2_+_233691607 | 1.23 |
ENST00000373424.5
ENST00000441351.1 |
UGT1A6
|
UDP glucuronosyltransferase family 1 member A6 |
chr14_-_106185387 | 1.23 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr1_+_207104226 | 1.23 |
ENST00000367070.8
|
C4BPA
|
complement component 4 binding protein alpha |
chr8_+_11704151 | 1.22 |
ENST00000526716.5
ENST00000532059.6 ENST00000335135.8 ENST00000622443.3 |
GATA4
|
GATA binding protein 4 |
chr10_-_5003850 | 1.22 |
ENST00000421196.7
ENST00000455190.2 ENST00000380753.8 |
AKR1C2
|
aldo-keto reductase family 1 member C2 |
chr22_+_22906342 | 1.22 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr2_+_210477708 | 1.21 |
ENST00000673711.1
|
CPS1
|
carbamoyl-phosphate synthase 1 |
chr11_-_60183191 | 1.20 |
ENST00000412309.6
|
MS4A6A
|
membrane spanning 4-domains A6A |
chr1_-_113871665 | 1.19 |
ENST00000528414.5
ENST00000460620.5 ENST00000359785.10 ENST00000420377.6 ENST00000525799.1 ENST00000538253.5 |
PTPN22
|
protein tyrosine phosphatase non-receptor type 22 |
chr14_+_94581880 | 1.19 |
ENST00000557598.1
ENST00000556064.1 |
SERPINA5
|
serpin family A member 5 |
chr1_-_147225309 | 1.19 |
ENST00000369272.7
ENST00000254090.9 ENST00000441068.6 |
FMO5
|
flavin containing dimethylaniline monoxygenase 5 |
chr16_-_1954682 | 1.18 |
ENST00000268661.8
|
RPL3L
|
ribosomal protein L3 like |
chr1_+_207089195 | 1.17 |
ENST00000452902.6
|
C4BPB
|
complement component 4 binding protein beta |
chr6_+_54018992 | 1.17 |
ENST00000509997.5
|
MLIP
|
muscular LMNA interacting protein |
chrY_+_12904860 | 1.16 |
ENST00000336079.8
|
DDX3Y
|
DEAD-box helicase 3 Y-linked |
chr2_+_233760265 | 1.16 |
ENST00000305208.10
ENST00000360418.4 |
UGT1A1
|
UDP glucuronosyltransferase family 1 member A1 |
chr15_-_21718245 | 1.16 |
ENST00000630556.1
|
ENSG00000281179.1
|
novel gene identicle to IGHV1OR15-1 |
chr11_-_60183011 | 1.16 |
ENST00000533023.5
ENST00000420732.6 ENST00000528851.6 |
MS4A6A
|
membrane spanning 4-domains A6A |
chr14_-_106374129 | 1.15 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr4_+_155903688 | 1.14 |
ENST00000536354.3
|
TDO2
|
tryptophan 2,3-dioxygenase |
chr5_-_35047935 | 1.13 |
ENST00000510428.1
ENST00000231420.11 |
AGXT2
|
alanine--glyoxylate aminotransferase 2 |
chr5_+_40841308 | 1.11 |
ENST00000381677.4
ENST00000254691.10 |
CARD6
|
caspase recruitment domain family member 6 |
chr2_+_201233443 | 1.10 |
ENST00000392263.6
ENST00000264274.13 ENST00000432109.6 ENST00000264275.9 ENST00000450491.5 ENST00000440732.5 ENST00000392258.7 |
CASP8
|
caspase 8 |
chr12_+_10179006 | 1.10 |
ENST00000298530.7
|
TMEM52B
|
transmembrane protein 52B |
chr12_+_112907006 | 1.10 |
ENST00000680455.1
ENST00000551241.6 ENST00000550689.2 ENST00000679841.1 ENST00000679494.1 ENST00000553185.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1 |
chr2_-_89245596 | 1.10 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr2_+_89851723 | 1.09 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr2_-_175181663 | 1.08 |
ENST00000392541.3
ENST00000284727.9 ENST00000409194.5 |
ATP5MC3
|
ATP synthase membrane subunit c locus 3 |
chr2_+_233692881 | 1.08 |
ENST00000305139.11
|
UGT1A6
|
UDP glucuronosyltransferase family 1 member A6 |
chr22_+_22380766 | 1.08 |
ENST00000390297.3
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr21_-_41767071 | 1.08 |
ENST00000352483.3
|
RIPK4
|
receptor interacting serine/threonine kinase 4 |
chr15_+_76336755 | 1.08 |
ENST00000290759.9
|
ISL2
|
ISL LIM homeobox 2 |
chr5_-_147831663 | 1.08 |
ENST00000296695.10
|
SPINK1
|
serine peptidase inhibitor Kazal type 1 |
chr11_-_13495984 | 1.08 |
ENST00000282091.6
|
PTH
|
parathyroid hormone |
chr16_-_55833186 | 1.07 |
ENST00000361503.8
ENST00000422046.6 |
CES1
|
carboxylesterase 1 |
chr4_-_68670648 | 1.07 |
ENST00000338206.6
|
UGT2B15
|
UDP glucuronosyltransferase family 2 member B15 |
chr4_+_89879532 | 1.07 |
ENST00000394980.5
|
MMRN1
|
multimerin 1 |
chr1_-_54623518 | 1.06 |
ENST00000302250.7
ENST00000371304.2 |
FAM151A
|
family with sequence similarity 151 member A |
chr2_-_178807415 | 1.06 |
ENST00000342992.10
ENST00000460472.6 ENST00000589042.5 ENST00000591111.5 ENST00000360870.10 |
TTN
|
titin |
chr11_+_57598184 | 1.06 |
ENST00000677625.1
ENST00000676670.1 |
SERPING1
|
serpin family G member 1 |
chr2_+_89947508 | 1.06 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr4_-_75940239 | 1.05 |
ENST00000505594.1
|
NAAA
|
N-acylethanolamine acid amidase |
chr14_+_22112280 | 1.05 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
chr1_-_11803383 | 1.05 |
ENST00000641407.1
ENST00000376583.7 ENST00000423400.7 |
MTHFR
|
methylenetetrahydrofolate reductase |
chr12_-_9999176 | 1.05 |
ENST00000298527.10
ENST00000348658.4 |
CLEC1B
|
C-type lectin domain family 1 member B |
chr12_-_7092422 | 1.04 |
ENST00000543835.5
ENST00000647956.2 ENST00000535233.6 |
C1R
|
complement C1r |
chr2_-_89027700 | 1.04 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr22_+_22375984 | 1.03 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr2_+_188974364 | 1.02 |
ENST00000304636.9
ENST00000317840.9 |
COL3A1
|
collagen type III alpha 1 chain |
chr4_+_101790607 | 1.02 |
ENST00000428908.5
|
BANK1
|
B cell scaffold protein with ankyrin repeats 1 |
chr14_-_106038355 | 1.02 |
ENST00000390597.3
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
chr1_+_207089233 | 1.02 |
ENST00000243611.9
ENST00000367076.7 |
C4BPB
|
complement component 4 binding protein beta |
chr1_+_159780930 | 1.01 |
ENST00000368109.5
ENST00000368108.7 ENST00000368107.2 |
DUSP23
|
dual specificity phosphatase 23 |
chr4_-_69214743 | 1.01 |
ENST00000446444.2
|
UGT2B11
|
UDP glucuronosyltransferase family 2 member B11 |
chr17_+_18952158 | 1.01 |
ENST00000395647.6
ENST00000417251.6 ENST00000395645.4 |
SLC5A10
|
solute carrier family 5 member 10 |
chr1_-_203182805 | 1.01 |
ENST00000404436.2
|
CHI3L1
|
chitinase 3 like 1 |
chr10_+_5048748 | 1.00 |
ENST00000602997.5
ENST00000439082.7 |
AKR1C3
|
aldo-keto reductase family 1 member C3 |
chr16_+_85914267 | 1.00 |
ENST00000569607.1
|
IRF8
|
interferon regulatory factor 8 |
chr1_+_207088825 | 1.00 |
ENST00000367078.8
|
C4BPB
|
complement component 4 binding protein beta |
chr12_+_100473708 | 1.00 |
ENST00000548884.5
ENST00000392986.8 |
NR1H4
|
nuclear receptor subfamily 1 group H member 4 |
chr5_-_147831627 | 1.00 |
ENST00000510027.2
|
SPINK1
|
serine peptidase inhibitor Kazal type 1 |
chr2_+_234050679 | 1.00 |
ENST00000373368.5
ENST00000168148.8 |
SPP2
|
secreted phosphoprotein 2 |
chr14_-_22819721 | 0.99 |
ENST00000554517.5
ENST00000285850.11 ENST00000397529.6 ENST00000555702.5 |
SLC7A7
|
solute carrier family 7 member 7 |
chr4_-_99144238 | 0.99 |
ENST00000512499.5
ENST00000504125.1 ENST00000505590.5 ENST00000629236.2 ENST00000508393.5 ENST00000265512.12 |
ADH4
|
alcohol dehydrogenase 4 (class II), pi polypeptide |
chr11_-_18236795 | 0.99 |
ENST00000278222.7
|
SAA4
|
serum amyloid A4, constitutive |
chr19_-_4535221 | 0.99 |
ENST00000381848.7
ENST00000586133.1 |
PLIN5
|
perilipin 5 |
chr1_-_56966006 | 0.99 |
ENST00000371237.9
|
C8B
|
complement C8 beta chain |
chr10_-_49762276 | 0.98 |
ENST00000374103.9
|
OGDHL
|
oxoglutarate dehydrogenase L |
chr2_-_73642413 | 0.98 |
ENST00000272425.4
|
NAT8
|
N-acetyltransferase 8 (putative) |
chrX_-_132489954 | 0.98 |
ENST00000370844.5
|
MBNL3
|
muscleblind like splicing regulator 3 |
chr7_-_95396349 | 0.97 |
ENST00000427422.5
ENST00000451904.5 ENST00000265627.10 |
PON3
|
paraoxonase 3 |
chr7_+_142345412 | 0.97 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
chr2_-_113241779 | 0.97 |
ENST00000497038.6
|
PAX8
|
paired box 8 |
chr6_+_116461364 | 0.97 |
ENST00000368606.7
ENST00000368605.3 |
CALHM6
|
calcium homeostasis modulator family member 6 |
chr12_-_7092484 | 0.97 |
ENST00000541042.5
ENST00000540242.2 |
C1R
|
complement C1r |
chr6_-_25874212 | 0.97 |
ENST00000361703.10
ENST00000397060.8 |
SLC17A3
|
solute carrier family 17 member 3 |
chr5_-_156935656 | 0.96 |
ENST00000406964.5
|
TIMD4
|
T cell immunoglobulin and mucin domain containing 4 |
chr2_-_178702479 | 0.95 |
ENST00000414766.5
|
TTN
|
titin |
chr3_-_185254028 | 0.95 |
ENST00000440662.1
ENST00000456310.5 ENST00000231887.8 |
EHHADH
|
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
chr7_+_107583919 | 0.95 |
ENST00000491150.5
|
BCAP29
|
B cell receptor associated protein 29 |
chr1_+_207104287 | 0.95 |
ENST00000421786.5
|
C4BPA
|
complement component 4 binding protein alpha |
chr19_-_32869741 | 0.95 |
ENST00000590341.5
ENST00000587772.1 ENST00000023064.9 |
SLC7A9
|
solute carrier family 7 member 9 |
chr2_-_223837484 | 0.94 |
ENST00000446015.6
ENST00000409375.1 |
AP1S3
|
adaptor related protein complex 1 subunit sigma 3 |
chr15_-_60391127 | 0.94 |
ENST00000559350.5
ENST00000558986.5 ENST00000560389.5 |
ANXA2
|
annexin A2 |
chr4_-_109801978 | 0.94 |
ENST00000510800.1
ENST00000512148.5 ENST00000394634.7 ENST00000394635.8 ENST00000645635.1 |
CFI
ENSG00000285330.1
|
complement factor I novel protein |
chr8_-_66962563 | 0.94 |
ENST00000563496.2
|
TCF24
|
transcription factor 24 |
chr17_-_41140487 | 0.93 |
ENST00000345847.4
|
KRTAP4-6
|
keratin associated protein 4-6 |
chr12_+_20810698 | 0.93 |
ENST00000540853.5
ENST00000381545.8 |
SLCO1B3
|
solute carrier organic anion transporter family member 1B3 |
chr3_+_111911604 | 0.93 |
ENST00000495180.1
|
PHLDB2
|
pleckstrin homology like domain family B member 2 |
chr3_+_46370854 | 0.93 |
ENST00000292303.4
|
CCR5
|
C-C motif chemokine receptor 5 |
chr14_-_94323389 | 0.92 |
ENST00000557225.1
|
SERPINA6
|
serpin family A member 6 |
chr21_-_41767042 | 0.91 |
ENST00000332512.8
|
RIPK4
|
receptor interacting serine/threonine kinase 4 |
chr12_-_46372763 | 0.91 |
ENST00000256689.10
|
SLC38A2
|
solute carrier family 38 member 2 |
chr7_+_142656688 | 0.90 |
ENST00000390397.2
|
TRBV24-1
|
T cell receptor beta variable 24-1 |
chr1_+_207089283 | 0.90 |
ENST00000391923.1
|
C4BPB
|
complement component 4 binding protein beta |
chr7_+_66075913 | 0.90 |
ENST00000362000.10
ENST00000395331.4 ENST00000671817.1 |
ASL
|
argininosuccinate lyase |
chr15_-_21742799 | 0.90 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
chrX_-_111270474 | 0.89 |
ENST00000324068.2
|
CAPN6
|
calpain 6 |
chr2_+_90038848 | 0.89 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr4_+_109912877 | 0.89 |
ENST00000265171.10
ENST00000509793.5 ENST00000652245.1 |
EGF
|
epidermal growth factor |
chr12_+_10179024 | 0.89 |
ENST00000543484.2
|
TMEM52B
|
transmembrane protein 52B |
chr7_+_138076475 | 0.88 |
ENST00000438242.1
|
AKR1D1
|
aldo-keto reductase family 1 member D1 |
chr4_-_74099187 | 0.88 |
ENST00000508487.3
|
CXCL2
|
C-X-C motif chemokine ligand 2 |
chr10_-_5185104 | 0.88 |
ENST00000648824.1
ENST00000650030.1 |
AKR1C8P
|
aldo-keto reductase family 1 member C8, pseudogene |
chr2_+_89936859 | 0.88 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
chr8_+_18210101 | 0.88 |
ENST00000307719.9
ENST00000518029.5 |
NAT1
|
N-acetyltransferase 1 |
chr7_+_142328282 | 0.87 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
chr6_+_106541111 | 0.87 |
ENST00000457437.1
|
CRYBG1
|
crystallin beta-gamma domain containing 1 |
chr19_-_54281082 | 0.87 |
ENST00000314446.10
|
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
chr10_+_5094405 | 0.87 |
ENST00000380554.5
|
AKR1C3
|
aldo-keto reductase family 1 member C3 |
chr19_+_44946043 | 0.86 |
ENST00000252490.7
ENST00000591597.5 |
APOC2
|
apolipoprotein C2 |
chr4_+_25160631 | 0.86 |
ENST00000510415.1
ENST00000507794.2 ENST00000512921.4 |
SEPSECS-AS1
PI4K2B
|
SEPSECS antisense RNA 1 (head to head) phosphatidylinositol 4-kinase type 2 beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.5 | GO:0003095 | pressure natriuresis(GO:0003095) |
1.1 | 4.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.0 | 3.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
1.0 | 5.8 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.9 | 4.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.9 | 5.2 | GO:0001080 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.8 | 4.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.8 | 2.5 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.8 | 2.4 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.8 | 6.9 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.7 | 16.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.7 | 2.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.6 | 2.6 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.6 | 1.9 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.6 | 1.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.6 | 2.8 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 2.5 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.5 | 6.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.5 | 1.4 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.4 | 1.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 1.7 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.4 | 1.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.4 | 1.7 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.4 | 4.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 1.6 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.4 | 1.2 | GO:1903717 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.4 | 1.2 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.4 | 3.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.4 | 1.5 | GO:0051413 | response to cortisone(GO:0051413) |
0.4 | 1.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 1.4 | GO:0052364 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.3 | 2.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 2.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.3 | 2.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.3 | 1.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 2.9 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.3 | 1.0 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.3 | 1.2 | GO:0003290 | atrial septum secundum morphogenesis(GO:0003290) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.3 | 5.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 2.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 1.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 0.8 | GO:0002458 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) |
0.3 | 1.9 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 1.1 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.3 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 3.5 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.3 | 1.1 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.3 | 0.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.3 | 3.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.3 | 2.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 36.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.2 | 0.7 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.2 | 2.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 1.6 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.2 | 0.7 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.2 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 3.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 0.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 1.1 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.2 | 0.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 0.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.2 | 0.6 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 1.7 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.2 | 0.8 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.2 | 0.6 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.2 | 0.6 | GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation(GO:0070145) |
0.2 | 0.8 | GO:0042223 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
0.2 | 0.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 1.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 1.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 0.8 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.2 | 1.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 1.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 2.2 | GO:0032328 | alanine transport(GO:0032328) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 0.7 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.2 | 0.5 | GO:0051552 | flavone metabolic process(GO:0051552) response to methionine(GO:1904640) |
0.2 | 0.5 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.2 | 0.5 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.2 | 0.7 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 1.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 1.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 3.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.4 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.1 | 0.4 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.1 | 0.7 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 1.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 0.6 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.1 | 0.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.1 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.9 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 1.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 1.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 1.8 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.5 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 4.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 1.0 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.1 | 0.6 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 0.6 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.1 | 0.4 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.1 | 0.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.1 | 0.2 | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
0.1 | 0.6 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.1 | 0.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.1 | 1.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.5 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 1.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.3 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.1 | 0.3 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
0.1 | 0.3 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.1 | 0.4 | GO:2000724 | mineralocorticoid receptor signaling pathway(GO:0031959) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 1.8 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.1 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 2.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.9 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.3 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 0.7 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.6 | GO:0035696 | monocyte extravasation(GO:0035696) |
0.1 | 1.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.3 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 1.3 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.3 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.4 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.3 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
0.1 | 0.3 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.1 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.5 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 1.0 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.2 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.1 | 1.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 1.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 0.4 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 0.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 1.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.2 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.1 | 0.4 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
0.1 | 0.3 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.1 | 0.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.5 | GO:0006196 | AMP catabolic process(GO:0006196) adenosine biosynthetic process(GO:0046086) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.2 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
0.1 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:2001311 | lysobisphosphatidic acid metabolic process(GO:2001311) |
0.1 | 1.6 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 0.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 1.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.4 | GO:0009197 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
0.1 | 0.4 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 1.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.5 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.1 | 0.4 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.1 | 0.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.2 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
0.1 | 0.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 1.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 0.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 2.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 1.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.2 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.3 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.2 | GO:1900114 | positive regulation of histone H3-K9 dimethylation(GO:1900111) positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.1 | 1.7 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.1 | 0.6 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.2 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 1.3 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.4 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.4 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 0.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.1 | 0.5 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.1 | 0.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.4 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.1 | 6.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.8 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 1.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 0.4 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.2 | GO:0051598 | meiotic recombination checkpoint(GO:0051598) |
0.1 | 2.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.4 | GO:0002860 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.6 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 1.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.3 | GO:1904499 | glial cell fate determination(GO:0007403) regulation of anagen(GO:0051884) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.0 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.5 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.0 | 0.3 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.0 | 0.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.0 | 0.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.0 | 0.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.7 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 1.0 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 9.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.0 | 4.2 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.4 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.0 | 0.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.6 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 1.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.5 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.0 | 1.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 1.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.9 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 1.2 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.0 | 0.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
0.0 | 0.3 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.4 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 1.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.3 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.0 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.2 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
0.0 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.8 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.0 | 0.1 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.0 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.9 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:1902941 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.2 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.1 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
0.0 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 2.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.0 | 0.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.0 | 0.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 1.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.3 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.0 | 1.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.0 | 0.2 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.0 | 0.3 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.0 | 0.4 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.0 | 0.1 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.0 | 0.1 | GO:0045939 | negative regulation of steroid metabolic process(GO:0045939) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.3 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.0 | 1.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.0 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.1 | GO:0033168 | conversion of ds siRNA to ss siRNA involved in RNA interference(GO:0033168) conversion of ds siRNA to ss siRNA(GO:0036404) |
0.0 | 0.6 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.1 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.0 | 0.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.1 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
0.0 | 0.1 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 1.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 1.0 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.4 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.2 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.0 | 0.2 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.0 | 0.7 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.4 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.8 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.5 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 1.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 1.3 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 1.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 0.5 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.2 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.0 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.7 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.5 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 1.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.0 | 0.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.6 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.0 | 0.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.0 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.4 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.0 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 1.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.0 | 0.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 1.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.0 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.0 | 0.3 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.0 | 0.0 | GO:0036292 | DNA rewinding(GO:0036292) |
0.0 | 0.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.0 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 4.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0021943 | interneuron migration from the subpallium to the cortex(GO:0021830) formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 1.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.0 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.3 | GO:0071757 | hexameric IgM immunoglobulin complex(GO:0071757) |
0.5 | 2.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.4 | 1.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.4 | 2.9 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 1.2 | GO:0036027 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.3 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 1.4 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.2 | 0.7 | GO:1990427 | stereocilia tip link(GO:0002140) myosin VII complex(GO:0031477) stereocilia tip-link density(GO:1990427) upper tip-link density(GO:1990435) |
0.2 | 1.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 5.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 3.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.5 | GO:1990844 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
0.2 | 1.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.5 | GO:0060342 | photoreceptor inner segment membrane(GO:0060342) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 8.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.6 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 5.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 27.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.6 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 1.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 1.7 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 0.5 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 2.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 6.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 0.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.8 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.1 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.1 | GO:0005713 | recombination nodule(GO:0005713) |
0.1 | 1.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 1.0 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.2 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
0.1 | 0.3 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.2 | GO:0090651 | apical cytoplasm(GO:0090651) |
0.1 | 0.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.1 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.5 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.1 | 0.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 2.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 6.8 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
0.0 | 0.1 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.0 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 1.0 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 1.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 3.2 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 1.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 2.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 2.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.1 | GO:0016590 | ACF complex(GO:0016590) |
0.0 | 0.1 | GO:0033167 | ARC complex(GO:0033167) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.0 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 1.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.0 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.6 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.3 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.0 | 0.5 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 1.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 1.0 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 2.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0071149 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.2 | 6.1 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.9 | 2.8 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.9 | 2.8 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.9 | 6.5 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 5.2 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.8 | 2.4 | GO:0004411 | homogentisate 1,2-dioxygenase activity(GO:0004411) |
0.8 | 4.5 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.7 | 3.4 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.6 | 1.9 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.6 | 1.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.6 | 1.2 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.6 | 3.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 2.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.5 | 23.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.4 | 1.6 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
0.4 | 1.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.4 | 1.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.3 | 0.7 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 2.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.3 | 1.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 1.2 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.3 | 0.9 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
0.3 | 2.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 0.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 0.8 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.3 | 4.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 3.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 1.3 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.3 | 0.8 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.3 | 0.8 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.3 | 2.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 2.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 0.7 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.2 | 0.7 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 0.7 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.2 | 0.9 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.2 | 1.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.2 | 1.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.6 | GO:0050560 | aspartate-tRNA ligase activity(GO:0004815) aspartate-tRNA(Asn) ligase activity(GO:0050560) |
0.2 | 1.5 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 1.7 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.2 | 0.6 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.2 | 1.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 2.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 1.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 0.7 | GO:0000035 | acyl binding(GO:0000035) phosphopantetheine binding(GO:0031177) |
0.2 | 0.7 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 48.9 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 2.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 1.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 0.7 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.2 | 0.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.3 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 1.0 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 2.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.6 | GO:0017057 | glucose-6-phosphate dehydrogenase activity(GO:0004345) 6-phosphogluconolactonase activity(GO:0017057) |
0.2 | 1.1 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.2 | 1.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.5 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
0.1 | 0.4 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.1 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 2.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.1 | 1.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.5 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.4 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 5.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.5 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
0.1 | 0.5 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.5 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.4 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
0.1 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 1.3 | GO:0015180 | hydrogen:amino acid symporter activity(GO:0005280) L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 2.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.3 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 0.3 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.1 | 0.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.1 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0015055 | secretin receptor activity(GO:0015055) |
0.1 | 0.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.1 | 0.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.3 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.1 | 2.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 1.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.4 | GO:0070224 | sulfide:quinone oxidoreductase activity(GO:0070224) |
0.1 | 1.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.3 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.1 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 3.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 1.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 2.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 3.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.2 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.1 | 0.8 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 2.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.2 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.1 | 0.2 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.4 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.1 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.4 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.2 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 3.7 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
0.1 | 0.4 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.5 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.1 | 0.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.7 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 1.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 1.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 1.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 1.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.0 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 2.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.3 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.0 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0015563 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 3.3 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 2.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 9.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 4.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 1.0 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.2 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.0 | 1.9 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 3.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.3 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 1.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.0 | GO:1990175 | EH domain binding(GO:1990175) |
0.0 | 0.1 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 1.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 1.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 4.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 1.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 1.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 9.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 4.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 4.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 3.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 5.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 1.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 4.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 3.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 2.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 2.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 3.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 11.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 2.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.0 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 1.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 21.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 10.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 5.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 4.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 3.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 2.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 1.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 4.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 3.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 2.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 3.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 3.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 6.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 6.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 3.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 2.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 2.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 10.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 1.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 2.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 1.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.6 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 2.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 1.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 1.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 2.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 1.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |